(Q24246151)

PubMed

PubMed publication ID

15494991

26 November 2023

AG Randolph

series ordinal

2

author given names

A

author last names

Randolph

1 reference

PubMed

PubMed publication ID

15494991

Cochrane Database of Systematic Reviews

26 November 2023

language of work or name

1 reference

18 October 2004

0 references

published in

0 references

cites work

Ribavirin in ventilated respiratory syncytial virus bronchiolitis. A randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000181.PUB2

Prospective follow-up and pulmonary functions from a placebo-controlled randomized trial of ribavirin therapy in respiratory syncytial virus bronchiolitis. Ribavirin Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000181.PUB2

Effect of ribavirin therapy on respiratory syncytial virus-specific IgE and IgA responses after infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000181.PUB2

Identifying relevant studies for systematic reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000181.PUB2

Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000181.PUB2

Ribavirin treatment of respiratory syncytial viral infection in infants with underlying cardiopulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000181.PUB2

7 January 2021

Respiratory system mechanics in patients receiving aerosolized ribavirin during mechanical ventilation for suspected respiratory syncytial viral infection.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000181.PUB2

7 January 2021

Antiviral therapy in neonatal chronic lung disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000181.PUB2

7 January 2021

Early ribavirin treatment of respiratory syncytial viral infection in high-risk children

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000181.PUB2

7 January 2021

High-dose, short-duration ribavirin aerosol therapy compared with standard ribavirin therapy in children with suspected respiratory syncytial virus infection

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000181.PUB2

7 January 2021

Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) prospective study of risk factors and outcomes in patients hospitalized with respiratory syncytial viral lower respiratory tract infection

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000181.PUB2

7 January 2021

The effect of ribavirin to treat previously healthy infants admitted with acute bronchiolitis on acute and chronic respiratory morbidity.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000181.PUB2

7 January 2021

Aerosolized ribavirin treatment of infants with respiratory syncytial viral infection. A randomized double-blind study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000181.PUB2

7 January 2021

A controlled trial of aerosolized ribavirin in infants receiving mechanical ventilation for severe respiratory syncytial virus infection

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000181.PUB2

7 January 2021

Ribavirin for severe RSV infection

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000181.PUB2

7 January 2021

Aerosolized ribavirin in mechanically ventilated children with respiratory syncytial virus lower respiratory tract disease: a prospective, double-blind, randomized trial.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000181.PUB2

7 January 2021

Ribavirin effect on pulmonary function in young infants with respiratory syncytial virus bronchiolitis.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000181.PUB2

7 January 2021

Long term follow-up of children hospitalized with respiratory syncytial virus lower respiratory tract infection and randomly treated with ribavirin or placebo

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000181.PUB2

7 January 2021

Safety issues related to the administration of ribavirin

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000181.PUB2

7 January 2021

Ribavirin aerosol for acute bronchiolitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000181.PUB2

7 January 2021

Early ribavarin treatment of bronchiolitis: effect on long-term respiratory morbidity.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000181.PUB2

7 January 2021

Bronchoconstrictive effect of ultrasonic nebulized distilled water on asthmatic children

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000181.PUB2

7 January 2021